181 related articles for article (PubMed ID: 31672935)
21. Activation of the Akt/mammalian target of rapamycin pathway in combined hepatocellular carcinoma and cholangiocarcinoma: significant correlation between p-4E-BP1 expression in cholangiocarcinoma component and prognosis.
Okumura Y; Kohashi K; Tanaka Y; Kato M; Maehara Y; Ogawa Y; Oda Y
Virchows Arch; 2020 Jun; 476(6):881-890. PubMed ID: 31927624
[TBL] [Abstract][Full Text] [Related]
22. Diabetes enhances translation of
Dierschke SK; Toro AL; Miller WP; Sunilkumar S; Dennis MD
J Biol Chem; 2020 Jul; 295(31):10831-10841. PubMed ID: 32475820
[TBL] [Abstract][Full Text] [Related]
23. mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells.
Jossé L; Xie J; Proud CG; Smales CM
Biochem J; 2016 Dec; 473(24):4651-4664. PubMed ID: 27760840
[TBL] [Abstract][Full Text] [Related]
24. TGF-β1-induced expression of collagen type II and ACAN is regulated by 4E-BP1, a repressor of translation.
Hwang HS; Lee MH; Kim HA
FASEB J; 2020 Jul; 34(7):9531-9546. PubMed ID: 32485037
[TBL] [Abstract][Full Text] [Related]
25. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
26. 4E-BP1 and 4E-BP2 double knockout mice are protected from aging-associated sarcopenia.
Le Bacquer O; Combe K; Patrac V; Ingram B; Combaret L; Dardevet D; Montaurier C; Salles J; Giraudet C; Guillet C; Sonenberg N; Boirie Y; Walrand S
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):696-709. PubMed ID: 30927336
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
[TBL] [Abstract][Full Text] [Related]
29. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
30. Amyloid precursor protein (APP) affects global protein synthesis in dividing human cells.
Sobol A; Galluzzo P; Liang S; Rambo B; Skucha S; Weber MJ; Alani S; Bocchetta M
J Cell Physiol; 2015 May; 230(5):1064-74. PubMed ID: 25283437
[TBL] [Abstract][Full Text] [Related]
31. New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
Golob-Schwarzl N; Puchas P; Gogg-Kamerer M; Weichert W; Göppert B; Haybaeck J
Anticancer Res; 2020 Jun; 40(6):3109-3118. PubMed ID: 32487605
[TBL] [Abstract][Full Text] [Related]
32. Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis.
Musa J; Orth MF; Dallmayer M; Baldauf M; Pardo C; Rotblat B; Kirchner T; Leprivier G; Grünewald TG
Oncogene; 2016 Sep; 35(36):4675-88. PubMed ID: 26829052
[TBL] [Abstract][Full Text] [Related]
33. The mTOR target 4E-BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency.
Magagnin MG; van den Beucken T; Sergeant K; Lambin P; Koritzinsky M; Devreese B; Wouters BG
Proteomics; 2008 Mar; 8(5):1019-28. PubMed ID: 18219697
[TBL] [Abstract][Full Text] [Related]
34. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
[TBL] [Abstract][Full Text] [Related]
35. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
[TBL] [Abstract][Full Text] [Related]
36. CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.
Shuda M; Velásquez C; Cheng E; Cordek DG; Kwun HJ; Chang Y; Moore PS
Proc Natl Acad Sci U S A; 2015 May; 112(19):5875-82. PubMed ID: 25883264
[TBL] [Abstract][Full Text] [Related]
37. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
[TBL] [Abstract][Full Text] [Related]
38. Distinct role of 4E-BP1 and S6K1 in regulating autophagy and hepatitis B virus (HBV) replication.
Gao Q; Hou B; Yang H; Jiang X
Life Sci; 2019 Mar; 220():1-7. PubMed ID: 30690083
[TBL] [Abstract][Full Text] [Related]
39. Translation control during prolonged mTORC1 inhibition mediated by 4E-BP3.
Tsukumo Y; Alain T; Fonseca BD; Nadon R; Sonenberg N
Nat Commun; 2016 Jun; 7():11776. PubMed ID: 27319316
[TBL] [Abstract][Full Text] [Related]
40. Significance of 4E-binding protein 1 as a therapeutic target for invasive urothelial carcinoma of the bladder.
Nishikawa M; Miyake H; Behnsawy HM; Fujisawa M
Urol Oncol; 2015 Apr; 33(4):166.e9-15. PubMed ID: 25618298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
